Get started
Author

David Vallée

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
2020 · Andrew J Pollard, Odile Launay, et al. · The Lancet Infectious Diseases · 164
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases
2024 · Aurélie Wiedemann, Edouard Lhomme, et al. · Nature Communications · 23
PDF
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults
2023 · Andrew W Lee, Ken Liu, et al. · Clinical Infectious Diseases · 19
PDF
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 19
PDF
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
2021 · Moses Badio, Edouard Lhomme, et al. · Trials · 18
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial
2024 · Simon Valayer, Marie Alexandre, et al. · Emerging Microbes & Infections · 4
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
Investigating immune amnesia after measles virus infection in two West African countries: A study protocol
2025 · Karine Fouth Tchos, Renée Ridzon, et al. · PLoS ONE · 3
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials
2025 · Kirk U. Knowlton, Lianne K. Siegel, et al. · PLoS Medicine · 2
PDF
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)
2025 · Sofía Sábato, Susana Benet, et al. · Scientific Reports
Works count: 14
Citation count: 393
H-index: 9
I10-index: 9
Year
Topic
Type